Amyloid beta, tau, synaptic, neurodegeneration, and glial biomarkers in the preclinical stage of the Alzheimer's continuum
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Amyloid beta, tau, synaptic, neurodegeneration, and glial biomarkers in the preclinical stage of the Alzheimer's
continuum
Authors
Keywords
-
Journal
Alzheimers & Dementia
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2020-06-23
DOI
10.1002/alz.12131
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Early increase of CSF sTREM2 in Alzheimer’s disease is associated with tau related-neurodegeneration but not with amyloid-β pathology
- (2019) Marc Suárez-Calvet et al. Molecular Neurodegeneration
- Cerebrospinal fluid biomarkers of neurodegeneration, synaptic integrity, and astroglial activation across the clinical Alzheimer's disease spectrum
- (2019) Isabelle Bos et al. Alzheimers & Dementia
- Emerging cerebrospinal fluid biomarkers in autosomal dominant Alzheimer's disease
- (2019) Suzanne E. Schindler et al. Alzheimers & Dementia
- Longitudinal cerebrospinal fluid biomarker trajectories along the Alzheimer's disease continuum in the BIOMARKAPD study
- (2019) Alberto Lleó et al. Alzheimers & Dementia
- Different pattern of CSF glial markers between dementia with Lewy bodies and Alzheimer’s disease
- (2019) Estrella Morenas-Rodríguez et al. Scientific Reports
- CSF biomarkers of Alzheimer's disease concord with amyloid-β PET and predict clinical progression: A study of fully automated immunoassays in BioFINDER and ADNI cohorts
- (2018) Oskar Hansson et al. Alzheimers & Dementia
- NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease
- (2018) Clifford R. Jack et al. Alzheimers & Dementia
- Relationship Between β-Secretase, Inflammation and Core Cerebrospinal Fluid Biomarkers for Alzheimer's Disease
- (2018) Daniel Alcolea et al. JOURNAL OF ALZHEIMERS DISEASE
- Longitudinal cognitive and biomarker changes in dominantly inherited Alzheimer disease
- (2018) Eric McDade et al. NEUROLOGY
- CSF sAPPβ, YKL-40, and NfL along the ALS-FTD spectrum
- (2018) Ignacio Illán-Gala et al. NEUROLOGY
- Age-specific and sex-specific prevalence of cerebral β-amyloidosis, tauopathy, and neurodegeneration in cognitively unimpaired individuals aged 50–95 years: a cross-sectional study
- (2017) Clifford R Jack et al. LANCET NEUROLOGY
- Cerebrospinal fluid soluble TREM2 is higher in Alzheimer disease and associated with mutation status
- (2016) Laura Piccio et al. ACTA NEUROPATHOLOGICA
- Imaging and cerebrospinal fluid biomarkers in early preclinical alzheimer disease
- (2016) Andrei G. Vlassenko et al. ANNALS OF NEUROLOGY
- Cerebrospinal fluid analysis detects cerebral amyloid-β accumulation earlier than positron emission tomography
- (2016) Sebastian Palmqvist et al. BRAIN
- Cerebrospinal fluid tau, neurogranin, and neurofilament light in Alzheimer's disease
- (2016) Niklas Mattsson et al. EMBO Molecular Medicine
- sTREM2 cerebrospinal fluid levels are a potential biomarker for microglia activity in early‐stage Alzheimer's disease and associate with neuronal injury markers
- (2016) Marc Suárez‐Calvet et al. EMBO Molecular Medicine
- CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis
- (2016) Bob Olsson et al. LANCET NEUROLOGY
- Oligomeric and phosphorylated alpha-synuclein as potential CSF biomarkers for Parkinson’s disease
- (2016) Nour K. Majbour et al. Molecular Neurodegeneration
- Increased cerebrospinal fluid soluble TREM2 concentration in Alzheimer’s disease
- (2016) Amanda Heslegrave et al. Molecular Neurodegeneration
- A/T/N: An unbiased descriptive classification scheme for Alzheimer disease biomarkers
- (2016) Clifford R. Jack et al. NEUROLOGY
- Increased CSF neurogranin concentration is specific to Alzheimer disease
- (2016) Henrietta Wellington et al. NEUROLOGY
- Early changes in CSF sTREM2 in dominantly inherited Alzheimers disease occur after amyloid deposition and neuronal injury
- (2016) M. Suarez-Calvet et al. Science Translational Medicine
- Cerebrospinal fluid soluble TREM2 in aging and Alzheimer’s disease
- (2016) Kristi Henjum et al. Alzheimers Research & Therapy
- Diagnostic and Prognostic Utility of the Synaptic Marker Neurogranin in Alzheimer Disease
- (2016) Rawan Tarawneh et al. JAMA Neurology
- Association of Cerebrospinal Fluid Neurofilament Light Concentration With Alzheimer Disease Progression
- (2016) Henrik Zetterberg et al. JAMA Neurology
- Neuroinflammation in Alzheimer's disease
- (2015) Michael T Heneka et al. LANCET NEUROLOGY
- Amyloid precursor protein metabolism and inflammation markers in preclinical Alzheimer disease
- (2015) Daniel Alcolea et al. NEUROLOGY
- Early astrocytosis in autosomal dominant Alzheimer’s disease measured in vivo by multi-tracer positron emission tomography
- (2015) Michael Schöll et al. Scientific Reports
- Associations Between Biomarkers and Age in the Presenilin 1 E280A Autosomal Dominant Alzheimer Disease Kindred
- (2015) Adam S. Fleisher et al. JAMA Neurology
- CSF neurofilament light differs in neurodegenerative diseases and predicts severity and survival
- (2014) T. Skillback et al. NEUROLOGY
- Longitudinal Change in CSF Biomarkers in Autosomal-Dominant Alzheimer's Disease
- (2014) A. M. Fagan et al. Science Translational Medicine
- Levels of cerebrospinal fluid α-synuclein oligomers are increased in Parkinson’s disease with dementia and dementia with Lewy bodies compared to Alzheimer’s disease
- (2014) Oskar Hansson et al. Alzheimers Research & Therapy
- Biomarker Modeling of Alzheimer’s Disease
- (2013) Clifford R. Jack et al. NEURON
- Regional variability of imaging biomarkers in autosomal dominant Alzheimer's disease
- (2013) T. L. S. Benzinger et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's Disease
- (2012) Randall J. Bateman et al. NEW ENGLAND JOURNAL OF MEDICINE
- YKL-40: A Novel Prognostic Fluid Biomarker for Preclinical Alzheimer's Disease
- (2010) Rebecca Craig-Schapiro et al. BIOLOGICAL PSYCHIATRY
- Detection of elevated levels of -synuclein oligomers in CSF from patients with Parkinson disease
- (2010) T. Tokuda et al. NEUROLOGY
- Synaptic degeneration in Alzheimer’s disease
- (2009) Thomas Arendt ACTA NEUROPATHOLOGICA
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started